- Conditions
- Essential Tremor
- Interventions
- SAGE-324, SAGE-324 Placebo
- Drug
- Lead sponsor
- Sage Therapeutics
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 69 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 27
- States / cities
- Phoenix, Arizona • Rogers, Arkansas • Fresno, California + 23 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–12
of 12
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Post-Traumatic Stress Disorder
- Interventions
- Brexanolone Injection [Zulresso]
- Drug
- Lead sponsor
- Donald Jeffrey Newport
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Pregnant Women, Psychotropic Drugs
- Interventions
- Not listed
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 5,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2033
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- PTSD, Alcohol Use Disorder
- Interventions
- Brexanolone
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 21 Years to 55 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Postpartum Psychosis
- Interventions
- Brexanolone
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Essential Tremor
- Interventions
- SAGE-547, Placebo
- Drug
- Lead sponsor
- Sage Therapeutics
- Industry
- Eligibility
- 35 Years to 75 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 2
- States / cities
- Bingham Farms, Michigan • Raleigh, North Carolina
- Conditions
- Postpartum Depression
- Interventions
- Brexanolone
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 10 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Essential Tremor
- Interventions
- SAGE-324
- Drug
- Lead sponsor
- Sage Therapeutics
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 38
- States / cities
- Hoover, Alabama • Scottsdale, Arizona • Fountain Valley, California + 32 more
- Conditions
- Healthy
- Interventions
- Ketamine
- Drug
- Lead sponsor
- ERP Biomarker Qualification Consortium
- Industry
- Eligibility
- 21 Years to 40 Years
- Enrollment
- 33 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Marlton, New Jersey
- Conditions
- Essential Tremor
- Interventions
- SAGE-324, SAGE-324 Matched Placebo
- Drug
- Lead sponsor
- Sage Therapeutics
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 146 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 51
- States / cities
- Hoover, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 45 more
- Conditions
- Schizophrenia
- Interventions
- Event-Related Potentials (ERP) and Electroencephalogram (EEG) testing with the COGNISION® System
- Device
- Lead sponsor
- ERP Biomarker Qualification Consortium
- Industry
- Eligibility
- 21 Years to 50 Years
- Enrollment
- 161 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 4
- States / cities
- Garden Grove, California • Torrance, California • Marlton, New Jersey + 1 more
- Conditions
- Acute Respiratory Distress Syndrome, COVID-19
- Interventions
- Brexanolone, Placebo
- Drug
- Lead sponsor
- Sage Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 9
- States / cities
- Fresno, California • Augusta, Georgia • Boston, Massachusetts + 6 more